Lisa Conte Net Worth

The estimated Net Worth of Lisa A Conte is at least $1.44 Million dollars as of 17 May 2024. Ms. Conte owns over 2,695 units of Jaguar Health Inc stock worth over $8,243 and over the last 8 years she sold JAGX stock worth over $0. In addition, she makes $1,433,160 as President, Chief Executive Officer, and Director at Jaguar Health Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Ms. Conte JAGX stock SEC Form 4 insiders trading

Lisa has made over 7 trades of the Jaguar Health Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently she exercised 2,695 units of JAGX stock worth $3,045 on 17 May 2024.

The largest trade she's ever made was exercising 45,000 units of Jaguar Health Inc stock on 5 April 2022 worth over $50,850. On average, Lisa trades about 2,907 units every 101 days since 2016. As of 17 May 2024 she still owns at least 7,295 units of Jaguar Health Inc stock.

You can see the complete history of Ms. Conte stock trades at the bottom of the page.

Lisa Conte biography

Lisa A. Conte serves as President, Chief Executive Officer, Director of the Company. Ms. Conte also serves as the Chief Executive Officer and a member of the board of our wholly-owned subsidiary, Napo Pharmaceuticals, Inc. ("Napo"), since she founded the company in November 2001. In 1989, Ms. Conte founded Shaman Pharmaceuticals, Inc., a natural product pharmaceutical company. Ms. Conte is also currently a member of the board of directors of Healing Forest Conservatory, a California not-for-profit public benefit corporation Ms. Conte holds an M.S. in Physiology and Pharmacology from the University of California, San Diego, and an M.B.A. and A.B. in Biochemistry from Dartmouth College.

What is the salary of Lisa Conte?

As the President, Chief Executive Officer, and Director of Jaguar Health Inc, the total compensation of Lisa Conte at Jaguar Health Inc is $1,433,160. There are no executives at Jaguar Health Inc getting paid more.

How old is Lisa Conte?

Lisa Conte is 61, she's been the President, Chief Executive Officer, and Director of Jaguar Health Inc since 2013. There are 6 older and 8 younger executives at Jaguar Health Inc. The oldest executive at Jaguar Health Inc is James Bochnowski, 76, who is the Independent Chairman of the Board.

What's Lisa Conte's mailing address?

Lisa's mailing address filed with the SEC is C/O JAGUAR HEALTH, INC., 200 PINE STREET, SUITE 400, SAN FRANCISCO, CA, 94104.

Insiders trading at Jaguar Health Inc

Over the last 9 years, insiders at Jaguar Health Inc have traded over $596,652 worth of Jaguar Health Inc stock and bought 670,772 units worth $1,311,594 . The most active insiders traders include Capital Partners, L.P.Sagar..., James J Bochnowski, and Investments Ltd Burford Cap.... On average, Jaguar Health Inc executives and independent directors trade stock every 66 days with the average trade being worth of $27,901. The most recent stock trade was executed by Pravin R Chaturvedi on 17 May 2024, trading 871 units of JAGX stock currently worth $984.

What does Jaguar Health Inc do?

jaguar health, inc. is a commercial stage natural-products pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. our wholly-owned subsidiary, napo pharmaceuticals, inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. our mytesi® (crofelemer) product is approved by the u.s. fda for the symptomatic relief of noninfectious diarrhea in adults with hiv/aids on antiretroviral therapy. canalevia™ is our lead animal prescription drug candidate, intended for treatment of various forms of diarrhea in dogs. equilevia™ is jaguar’s non-prescription product for total gut health in equine athletes. to read our full social media policy, please visit https://jaguar.health/social-media-policy/

Complete history of Ms. Conte stock trades at Jaguar Health Inc

Jaguar Health Inc executives and stock owners

Jaguar Health Inc executives and other stock owners filed with the SEC include:

• Lisa Conte,
  President, Chief Executive Officer, Director
• Steven King,
  Executive Vice President - Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary
• Lisa A. Conte,
  Founder, CEO, Pres & Director
• Jonathan Wolin,
  Chief of Staff, General Counsel and Chief Compliance Officer
• Jonathan S. Wolin CPA, J.D., M.B.A.,
  Chief of Staff, Chief Compliance Officer & Gen. Counsel
• Dr. Steven R. King,
  Chief Sustainable Supply, Ethnobotanical Research & Intellectual Property and Sec.
• James Bochnowski,
  Independent Chairman of the Board
• Jonathan Siegel,
  Independent Director
• Jiahao Qiu,
  Independent Director
• John Micek,
  Independent Director
• Gregory Divis,
  Independent Director
• Melissa Yeager,
  Senior Vice President - Regulatory Affairs & Quality Assurance
• Carol Lizak,
  Senior Vice President - Finance, Chief Accounting Officer
• Melissa A. Yeager J.D.,
  Sr. VP of Regulatory Affairs & Quality Assurance
• Ian H. Wendt M.B.A.,
  Chief Commercial Officer
• David Sesin,
  Chief Manufacturing Officer
• Dr. Karen Brunke Ph.D.,
  Exec. VP of Corp. & Bus. Devel.
• Peter Hodge,
  Sr. Director of Investor Relations, Bus. Devel. & Special Events
• Dr. Pravin R. Chaturvedi Ph.D.,
  Chair of Scientific Advisory Board & Acting Chief Scientific Officer
• Carol R. Lizak,
  Chief Financial Officer
• Roger J. Waltzman,
  Chief Scientific Officer
• Folkert W. Kamphuis,
  Director
• Philippe Brianceau,
  Chief Veterinary Officer
• Murray David Mac Naughtan,
  
• Zhi Yang,
  Director
• Ari Azhir,
  Director
• Karen Steil Wright,
  CFO and Treasurer
• Jeffery C. Johnson,
  
• Jonathan M Glaser,
  
• Bryan Bryan Ezralow 1994 Tr...,
  
• Investments Ltd Burford Cap...,
  
• Capital Partners, L.P.Sagar...,
  
• John A Kallassy,
  CFO, COO, Treasurer
• Management, Ltd.Kunlun Phar...,
  
• Michael Hauser,
  Chf Veterinarian, Clinical Ops
• Anula Jayasuriya,
  Director
• Pravin R Chaturvedi,
  Chief Scientific Officer